Investor Relations

Press Releases

07/31/19
Conformis Reports Second Quarter 2019 Financial Results and Updates Product Revenue Expectations
BILLERICA, Mass. , July 31, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique
07/15/19
Conformis Establishes Alliance to Focus on ASC Joint Replacement
BILLERICA, Mass. , July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique
07/15/19
Conformis to Host Second Quarter 2019 Financial Results Webcast on July 31, 2019
BILLERICA, Mass. , July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, July 31, 2019 , at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter ended June 30 , 2019.  The webcast will be live at:
06/25/19
Conformis Secures Up to $30 Million in Debt Financing and $3 Million in Equity Financing from Innovatus Life Sciences and East West Bank
BILLERICA, Mass. , June 25, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique
05/01/19
Conformis Reports First Quarter 2019 Financial Results
BILLERICA, Mass. , May 01, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique
04/23/19
New Peer Reviewed Data Supports Use of Conformis Customized Knee Implants to Match Anatomic Variability in Patients
BILLERICA, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants customized to fit each patient’s unique anatomy, today
04/17/19
Conformis to Host First Quarter 2019 Financial Results Webcast on May 1, 2019
BILLERICA, Mass. , April 17, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, May 1, 2019 , at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31 , 2019.  The webcast will be live at:
03/13/19
The 3D designed Conformis Hip System Announced at the 2019 AAOS conference
Designed to enhance operational efficiency for the surgeon and improve patient outcomes, the Conformis Hip System is the most advanced, patient conforming hip replacement system available BILLERICA, Mass. , March 13, 2019 (GLOBE NEWSWIRE) -- Conformis Inc.
02/18/19
Customized Knee Implants Drive Significant Cost Savings in a Medicare Population – Abstract Presented at Annual Knee Society Meeting
12-month average spending was $1,697 less for Medicare Fee for Service members who received customized implants compared to members who received standard off-the-shelf implants BILLERICA, Mass. , Feb. 18, 2019 (GLOBE NEWSWIRE) -- Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses
02/06/19
Conformis Reports Fourth Quarter and Year Ended 2018 Financial Results
BILLERICA, Mass. , Feb. 06, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique
01/23/19
Conformis to Host Fourth Quarter and Fiscal Year 2018 Financial Results Webcast on February 6, 2019
BILLERICA, Mass. , Jan. 23, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, February 6, 2019 , at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31 , 2018.  The webcast
01/08/19
Conformis Reports Preliminary Fourth Quarter and Year-End 2018 Revenue Results
BILLERICA, Mass. and SAN FRANCISCO , Jan. 08, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique